Association between adherence to statin therapy and low-density lipoprotein cholesterol (LDL-c) response in first-time users of standard-dose and low-dose statins: the PharmLines initiative

Irawati, Sylvi and Emmens, Johanna E. and de Vos, Stijn and Bos, Jens H.J. and de Boer, Rudolf A. and Hak, E. (2021) Association between adherence to statin therapy and low-density lipoprotein cholesterol (LDL-c) response in first-time users of standard-dose and low-dose statins: the PharmLines initiative. Current Medical Research and Opinion, 38 (1). pp. 1-6. ISSN 1473-4877

[thumbnail of Association between adherence to statin therapy and low density lipoprotein cholesterol LDL c response in first time users of standard dose and low.pdf] PDF
Association between adherence to statin therapy and low density lipoprotein cholesterol LDL c response in first time users of standard dose and low.pdf - Published Version
Restricted to Repository staff only

Download (1MB) | Request a copy
Official URL / DOI: https://doi.org/10.1080/03007995.2021.1984222

Abstract

Objective: To investigate whether statin adherence (defined as proportion days covered, PDC) is associated with LDL-c response in statin initiators on standard and low starting doses of statins, and to detect a possible interaction with sex. Methods: An inception cohort study was conducted using the PharmLines Initiative, a linkage between the Lifelines Cohort Study and the University of Groningen's IADB.nl (prescription database). First-time statin users were followed from baseline to follow-up measurement. We matched participants (1:1) between the standard-dose and the low-dose group of statin users on the duration of follow-up. Multiple linear regression analysis was used to model the association. Results: In univariate analysis, PDC was significantly associated with LDL-c response similarly (slope = -0.021), in both the standard-dose group (N = 115, p < .001) and the low-dose group (N = 115, p = .003). In the standard-dose group, the same level of PDC appeared to be significantly associated with a greater LDL-c level reduction in women (slope = -0.027, N = 48, p < .001) than in men (slope = -0.017, N = 67, p < .001). Meanwhile, in the low-dose group, the reduction of LDL-c level from baseline seemed to be greater in men (slope = -0.023, N = 56, p < .001) than in women (slope = -0.020, N = 59, p < .001) for the same level of PDC. In multiple regression analysis, the significant association between PDC and LDL-c with a similar pattern to the univariate result was maintained only in the standard-dose group. Conclusions: Adherence is significantly associated with LDL-c response to statins at follow-up. Sex appears to significantly modify this association. At a similar adherence level, women seem to experience a better LDL-c response to standard-dose statins compared to men in a real-world setting.

Item Type: Article
Uncontrolled Keywords: Adherence; statins; low- density-lipoprotein choles- terol; LDL-c
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Pharmacy > Department of Pharmacy
Depositing User: Sylvi Irawati, M.Farm., Apt. 208004
Date Deposited: 21 Feb 2022 02:39
Last Modified: 21 Feb 2022 02:39
URI: http://repository.ubaya.ac.id/id/eprint/41344

Actions (login required)

View Item View Item